TEDDM1 Inhibitors
Chemical inhibitors of TEDDM1 can modulate the activity of this protein through various mechanisms by targeting different signaling pathways that are crucial for its function. Staurosporine, a potent kinase inhibitor, can lead to a decrease in TEDDM1 activity by inhibiting the phosphorylation processes essential for TEDDM1 function, as protein kinases are responsible for adding phosphate groups to proteins, which can alter their activity and function. Similarly, Bisindolylmaleimide I, which selectively inhibits protein kinase C (PKC), can decrease TEDDM1 activity by disrupting PKC-mediated signaling pathways, potentially affecting the phosphorylation status of TEDDM1 or proteins that interact with it.
Further down the signaling cascade, LY294002 and Wortmannin, both inhibitors of phosphoinositide 3-kinases (PI3K), can lead to reduced TEDDM1 activity by preventing the downstream signaling events that PI3K initiates, which may be necessary for the proper function of TEDDM1. PD98059 and U0126, inhibitors of mitogen-activated protein kinase kinase (MEK), can reduce TEDDM1 activity through the inhibition of the MAPK/ERK pathway, which may regulate the activity or expression of TEDDM1. SB203580's selective inhibition of p38 MAP kinase and SP600125's inhibition of c-Jun N-terminal kinase (JNK) can each result in decreased TEDDM1 activity by interfering with their respective signaling pathways, which might be involved in the regulation of TEDDM1. PP2, an inhibitor of Src family tyrosine kinases, can decrease TEDDM1 activity by disrupting Src kinase-mediated phosphorylation cascades that could control TEDDM1 function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Since TEDDM1 is involved in signal transduction pathways that require kinase activity for protein phosphorylation, staurosporine can inhibit those kinases, leading to a reduction in TEDDM1 activity due to a lack of necessary phosphorylation events. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I selectively inhibits protein kinase C (PKC). If TEDDM1's activity is regulated by PKC-mediated signaling, the inhibition of PKC can result in decreased TEDDM1 activity due to the disruption of PKC-dependent signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K). Since PI3K signaling is critical for various cellular functions, the inhibition of PI3K can lead to a decrease in TEDDM1 activity by reducing the phosphorylation states of downstream targets that may be necessary for TEDDM1 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK). MEK is part of the MAPK/ERK pathway which may regulate TEDDM1 activity. Inhibition of MEK by PD98059 would lead to reduced ERK activation, and consequently, a decrease in TEDDM1 activity that is dependent on this signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase. If TEDDM1 activity is modulated by p38 MAPK-mediated signaling, the inhibition of p38 MAPK by SB203580 can lead to a decrease in TEDDM1 activity due to disruption of the signal transduction pathway that involves p38 MAPK. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). By inhibiting JNK, SP600125 can decrease TEDDM1 activity if TEDDM1 is involved in cellular processes that are regulated by JNK signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor like LY294002. The inhibition of PI3K by Wortmannin can lead to decreased TEDDM1 activity by preventing the downstream signaling events required for TEDDM1 functionality. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. If TEDDM1 activity is regulated by Src family kinase signaling, the inhibition of these kinases by PP2 can lead to a decrease in TEDDM1 activity through the disruption of Src kinase-mediated phosphorylation cascades. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor like PD98059. Inhibition of MEK by U0126 would reduce ERK pathway activity, potentially leading to decreased TEDDM1 activity if TEDDM1 is regulated by the MEK/ERK pathway. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor with activity against BCR-ABL and Src family kinases. By inhibiting these kinases, Dasatinib can decrease TEDDM1 activity if TEDDM1 is regulated by signal transduction involving these tyrosine kinases. | ||||||